• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Israel In Vitro Diagnostics Market Outlook to 2016 - Product Image

Israel In Vitro Diagnostics Market Outlook to 2016

  • ID: 1287889
  • July 2010
  • Region: Israel
  • 174 pages
  • GlobalData

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMerieux S.A.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • OLYMPUS CORPORATION
  • Qiagen N.V.
  • MORE

Israel In Vitro Diagnostics Market Outlook to 2016

Summary

Our new report, “Israel In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Israel In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories - clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics (IVD) market categories - clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, READ MORE >

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMerieux S.A.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • OLYMPUS CORPORATION
  • Qiagen N.V.
  • MORE

1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 In Vitro Diagnostics In Israel
3.1 In Vitro Diagnostics, Market Segmentation
3.2 In Vitro Diagnostics, Israel, Overall Revenue ($m), 2002-2016
3.3 In Vitro Diagnostics Market, Israel, Revenue Mix ($m), 2009
3.4 In Vitro Diagnostics Market, Israel, Category Contribution (%), 2009
3.5 In Vitro Diagnostics, Israel, Company Share (2008-2009)
4 Clinical Chemistry In Israel
4.1 Clinical Chemistry, Market Segmentation
4.2 Clinical Chemistry Market, Israel, Revenue Mix ($m), 2009
4.3 Clinical Chemistry Market, Israel, Category Contribution (%), 2009
4.4 Clinical Chemistry Overall Revenue (2002-2016)
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016)
4.4.2 Urine Analysis Revenue (2002-2016)
4.5 Clinical Chemistry Distribution Share (2008-2009)
4.6 Clinical Chemistry, Israel, Company Share (2008-2009)
5 Genetic Testing In Israel
5.1 Genetic Testing, Market Segmentation
5.2 Genetic Testing Market, Israel, Revenue Mix ($m), 2009
5.3 Genetic Testing Market, Israel, Category Contribution (%), 2009
5.4 Genetic Testing Overall Revenue (2002-2016)
5.5 Genetic Testing Distribution Share (2008-2009)
5.6 Genetic Testing, Israel, Company Share (2008-2009)
6 Haematology In Israel
6.1 Haematology, Market Segmentation
6.2 Haematology Market, Israel, Revenue Mix ($m), 2009
6.3 Haematology Market, Israel, Category Contribution (%), 2009
6.4 Haematology Overall Revenue (2002-2016)
6.4.1 Haematology Reagents Revenue (2002-2016)
6.4.2 Immunohaematology Revenue (2002-2016)
6.4.3 Haemostasis Revenue (2002-2016)
6.4.4 Haematology Rapid Tests Revenue (2002-2016)
6.4.5 Haematology Cell Counters Revenue (2002-2016)
6.5 Haematology Distribution Share (2008-2009)
6.6 Haematology, Israel, Company Share (2008-2009)
7 Histology And Cytology In Israel
7.1 Histology and Cytology, Market Segmentation
7.2 Histology and Cytology Market, Israel, Revenue Mix ($m), 2009
7.3 Histology and Cytology Market, Israel, Category Contribution (%), 2009
7.4 Histology and Cytology Overall Revenue (2002-2016)
7.4.1 Histology Revenue (2002-2016)
7.5 Histology and Cytology Distribution Share (2008-2009)
7.6 Histology and Cytology, Israel, Company Share (2008-2009)
8 Immuno Chemistry In Israel
8.1 Immuno Chemistry, Market Segmentation
8.2 Immuno Chemistry Market, Israel, Revenue Mix ($m), 2009
8.3 Immuno Chemistry Market, Israel, Category Contribution (%), 2009
8.4 Immuno Chemistry Overall Revenue (2002-2016)
8.4.1 Disease Specific Immunochemistry Revenue (2002-2016)
8.4.2 Drug Related Testing Revenue (2002-2016)
8.4.3 Endocrinology Tests Revenue (2002-2016)
8.4.4 Immunochemistry Analyzers Revenue (2002-2016)
8.5 Immuno Chemistry Distribution Share (2008-2009)
8.6 Immuno Chemistry, Israel, Company Share (2008-2009)
9 Infectious Immunology In Israel
9.1 Infectious Immunology, Market Segmentation
9.2 Infectious Immunology Market, Israel, Revenue Mix ($m), 2009
9.3 Infectious Immunology Market, Israel, Category Contribution (%), 2009
9.4 Infectious Immunology Overall Revenue (2002-2016)
9.5 Infectious Immunology Distribution Share (2008-2009)
9.6 Infectious Immunology, Israel, Company Share (2008-2009)
10 Microbiology Culture In Israel
10.1 Microbiology Culture, Market Segmentation
10.2 Microbiology Culture Market, Israel, Revenue Mix ($m), 2009
10.3 Microbiology Culture Market, Israel, Category Contribution (%), 2009
10.4 Microbiology Culture Overall Revenue (2002-2016)
10.4.1 Microbiology Analyzers Revenue (2002-2016)
10.5 Microbiology Culture Distribution Share (2008-2009)
10.6 Microbiology Culture, Israel, Company Share (2008-2009)
11 Overview of Key Companies in Israel In Vitro Diagnostics Market
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 Company Overview
11.1.2 Share in the Israel In Vitro Diagnostics Market
11.2 Abbott Laboratories
11.2.1 Company Overview
11.2.2 Share in the Israel In Vitro Diagnostics Market
11.3 bioMerieux S.A.
11.3.1 Company Overview
11.3.2 Share in the Israel In Vitro Diagnostics Market
11.4 Beckman Coulter, Inc.
11.4.1 Company Overview
11.4.2 Share in the Israel In Vitro Diagnostics Market
11.5 Ortho-Clinical Diagnostics Inc.
11.5.1 Company Overview
11.5.2 Share in the Israel In Vitro Diagnostics Market
11.6 Siemens Healthcare
11.6.1 Company Overview
11.6.2 Share in the Israel In Vitro Diagnostics Market
11.7 Inverness Medical Innovations, Inc.
11.7.1 Company Overview
11.8 Becton, Dickinson and Company
11.8.1 Company Overview
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Company Overview
11.10 Hologic, Inc.
11.10.1 Company Overview
11.11 OLYMPUS CORPORATION
11.11.1 Company Overview
11.12 Sysmex Corporation
11.12.1 Company Overview
11.13 Ventana Medical Systems, Inc.
11.13.1 Company Overview
11.14 DiaSorin S.p.A
11.14.1 Company Overview
11.15 Qiagen N.V.
11.15.1 Company Overview
11.16 Gen-Probe Incorporated
11.16.1 Company Overview
11.17 Phadia AB
11.17.1 Company Overview
11.18 Glycominds Ltd.
11.18.1 Company Overview
11.19 Savyon Diagnostics Ltd.
11.19.1 Company Overview
11.20 QuantomiX Ltd.
11.20.1 Company Overview
11.21 Pronto Diagnostics Ltd.
11.21.1 Company Overview
11.22 Hy Laboratories Ltd.
11.22.1 Company Overview
11.23 Zer Hitech (1976) Ltd
11.23.1 Company Overview
11.24 Meytav Technological Incubator
11.24.1 Company Overview
11.25 BioView Ltd.
11.25.1 Company Overview
11.26 MND Diagnostic LTD
11.26.1 Company Overview
11.27 Aposense Ltd.
11.27.1 Company Overview
12 In Vitro Diagnostics Market Pipeline Products
12.1 Clinical Chemisty Market Pipeline Products
12.2 Immuno Chemistry Market Pipeline Products
12.3 Haematology Market Pipeline Products
12.4 Infectious Immunology Market Pipeline Products
12.5 Microbiology Culture Market Pipeline Products
12.6 Histology and Cytology Market Pipeline Products
12.7 Genetic Testing Market Pipeline Products
13 Financial Deals Landscape
13.1 Partnerships
13.1.1 QIAGEN Enters Into Distribution Agreement with Celera
13.1.2 Sequenom Enters Into Licensing Agreement With Optherion
13.1.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University
13.1.4 OraSure Technologies Enters Into An Agreement With Roche Diagnostics
13.1.5 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal
13.1.6 Clarient Enters Into An Agreement With BioView
13.1.7 bioTheranostics Signs An Agreement With Lab21
14 Recent Developments
14.1 Product News
14.1.1 Mar 25, 2010: Study Finds Standardized Measure Using SMARTube Technology to Estimate Rate of Spread of HIV in High-Risk Populations
14.1.2 Mar 23, 2010: ACC Conference Highlights Studies On Assessing Cardiovascular Risk Using Itamar-Medical's EndoPAT In High And Low Risk Patients
14.1.3 Feb 04, 2010: Arrayit Gains Patent Protection From Israel For Its VIP DNA Testing Technology
14.1.4 Nov 17, 2009: Autogenomics Commercializes INFINITI System In Israel Through Medison Pharma
15 Appendix
15.1 Definitions of Markets Covered in the Report
15.1.1 In Vitro Diagnostics
15.2 Research Methodology
15.3 Secondary Research
15.4 Primary Research
15.5 Models
15.6 Forecasts
15.7 Expert Panels
15.8 Consulting
15.9 Currency Conversion
15.10 Contact Us
15.11 Disclaimer

F. Hoffmann-La Roche Ltd.
Abbott Laboratories
bioMerieux S.A.
Beckman Coulter, Inc.
Ortho-Clinical Diagnostics Inc.
Siemens Healthcare
Inverness Medical Innovations, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Hologic, Inc.
OLYMPUS CORPORATION
Sysmex Corporation
Ventana Medical Systems, Inc.
DiaSorin S.p.A
Qiagen N.V.
Gen-Probe Incorporated
Phadia AB
Glycominds Ltd.
Savyon Diagnostics Ltd.
QuantomiX Ltd.
Pronto Diagnostics Ltd.
Hy Laboratories Ltd.
Zer Hitech (1976) Ltd
Meytav Technological Incubator
BioView Ltd.
MND Diagnostic LTD
Aposense Ltd.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos